Search Results - Yu. B. Basok

Refine Results
  1. 1

    TISSUE ENGINEERING AND REGENERATIVE MEDICINE TECHNOLOGIES IN THE TREATMENT OF ARTICULAR CARTILAGE DEFECTS by Yu. B. Basok, V. I. Sevastianov

    Published 2017-01-01

    Some of the most pressing health problems of the industrial society are the damage and degeneration of articular cartilage associated with the limited capacity of tissues to regenerate. The review describes the existing and developing technologies for the recovery and replacement of damaged joint ca...

    Full description

    Get full text
    Article
  2. 2

    Transcutaneous permeation enhancer complex for polymer-based transdermal patches by E. G. Kuznetsova, L. A. Salomatina, O. M. Kuryleva, Yu. B. Basok, V. I. Sevastianov

    Published 2025-03-01

    Selecting a permeation enhancer complex (PEC) for inclusion in a matrix-type transdermal patch (TP) is a primary task in creating a new dosage form with percutaneous administration. Objective: to develop a biologically safe PEC capable of regulating percutaneous diffusion of low-molecular-weight dru...

    Full description

    Get full text
    Article
  3. 3

    Application of tissue engineering technology for formation of human articular cartilage in perfusion bioreactor by V. I. Sevastianov, Yu. B. Basok, A. M. Grigoriev, L. A. Kirsanova, V. N. Vasilets

    Published 2017-09-01

    Formation of tissue-engineered construct was performed in a specially developed bioreactor. At first, a cellengineered construct of human cartilage tissue consisting of biopolymer microstructured collagen-containing hydrogel, mesenchymal stromal cells of human adipose tissue (hADMSCs) and induction...

    Full description

    Get full text
    Article
  4. 4

    Obtaining a mouse model of streptozotocininduced type 1 diabetes mellitus by G. N. Skaletskaya, N. N. Skaletskiy, G. N. Bubentsova, L. A. Kirsanova, Yu. B. Basok, V. I. Sevastianov

    Published 2024-07-01

    Objective: to obtain a stable mouse model of type 1 diabetes mellitus (T1DM) using streptozotocin (STZ), which has a toxic effect on pancreatic beta cells.Materials and methods. Experiments were performed on 30 white non-diabetic male mice of the SHK colony, which were injected intraperitoneally wit...

    Full description

    Get full text
    Article
  5. 5

    Decellularized umbilical cord stroma in tissue engineering and regenerative medicine: a systematic review by Yu. B. Basok, A. A. Kondratenko, L. I. Kalyuzhnaya, E. A. Volkova, K. A. Vorobyov, V. I. Sevastianov

    Published 2023-07-01

    Despite great progress in the field of biomaterials for tissue engineering and regenerative medicine, the high requirements placed on artificial matrices (matrices, carriers, scaffolds) are the reason for the ongoing search for natural or synthetic extracellular matrix mimetics. Among such materials...

    Full description

    Get full text
    Article
  6. 6

    Biocompatible and functional properties of a microdispersed tissue-specific 3D matrix from decellularized porcine cartilage by E. A. Nemets, A. E. Lazhko, A. M. Grigoriev, Yu. B. Basok, A. D. Kirillova, V. I. Sevastianov

    Published 2022-12-01

    In contrast to decellularization of soft tissues for use as tissue-specific matrices in the creation of tissue-engineered constructs, decellularization of cartilage tissue requires several processing techniques, which can negatively affect the biocompatibility and functional properties of the native...

    Full description

    Get full text
    Article
  7. 7

    Use of mesenchymal stem cells in solid organ transplantation: challenges and prospects (systematic review) by Yu. B. Basok, A. S. Ponomareva, N. V. Grudinin, D. N. Kruglov, V. K. Bogdanov, A. D. Belova, V. I. Sevastianov

    Published 2025-03-01

    Organ transplantation continues to be the gold standard for saving the lives of patients with end-stage organ diseases. Its goal is to help recipients live longer and better lives. However, despite advancements, organ transplantation still faces serious challenges, such as organ shortage and the eff...

    Full description

    Get full text
    Article
  8. 8

    Impact of pancreatic cell-engineered constructs on the islet apparatus in recipient rats with type I diabetes mellitus by N. V. Baranova, L. A. Kirsanova, G. N. Bubentsova, A. S. Ponomareva, A. O. Nikolskaya, Yu. B. Basok, V. I. Sevastianov

    Published 2025-07-01

    Current research focuses on exploring strategies to stimulate the regenerative capacity of pancreatic beta cells as a potential therapeutic approach for diabetes mellitus (DM).Objective: this study aims to perform a comparative histological analysis of the islet apparatus in rats with streptozotocin...

    Full description

    Get full text
    Article
  9. 9

    Chemical decellularization of porcine liver by two-stage treatment with surfactants and osmoregulators enhances preservation of liver extracellular matrix structure by A. D. Belova, E. A. Nemets, D. D. Filin, A. S. Ponomareva, L. A. Kirsanova, Yu. B. Basok, V. I. Sevastianov

    Published 2025-03-01

    Objective: to develop and investigate a tissue-specific matrix obtained using a modified chemical porcine liver decellularization regime in order to effectively increase preservation of extracellular matrix (ECM) structure, reduce decellularization time and improve purification of the ECM from cellu...

    Full description

    Get full text
    Article
  10. 10

    Functional efficiency of pancreatic cell-engineered construct in an animal experimental model for type I diabetes by N. V. Baranova, A. S. Ponomareva, L. A. Kirsanova, A. O. Nikolskaya, G. N. Bubentsova, Yu. B. Basok, V. I. Sevastianov

    Published 2024-07-01

    The creation of a cell-engineered pancreatic construct (CEPC) from islets of Langerhans and biocompatible matrix carrier (framework/scaffold), which imitates the native microenvironment of pancreatic tissue, is an approach to the treatment of type I diabetes mellitus (T1D).The objective of this work...

    Full description

    Get full text
    Article
  11. 11

    On the possibility of therapeutic action after transdermal patch application by E. G. Kuznetsova, O. M. Kuryleva, L. A. Salomatina, S. V. Kursakov, V. Yu. Belov, Z. Z. Gonikova, Yu. B. Basok, V. I. Sevastianov

    Published 2022-07-01

    Background. As scientific knowledge about the peculiarities of the structure and functional properties of the skin increased, it became clearer that during transdermal administration, drug may accumulate in the deep layers of the dermis and subsequently get diffused into the bloodstream even after t...

    Full description

    Get full text
    Article
  12. 12

    Decellularization of donor pancreatic fragment to obtain a tissue-specific matrix scaffold by A. S. Ponomareva, L. A. Kirsanova, N. V. Baranova, V. A. Surguchenko, G. N. Bubentsova, Yu. B. Basok, I. A. Miloserdov, V. I. Sevastianov

    Published 2020-04-01

    One of the pressing issues in tissue engineering is on how to obtain an artificial matrix that can simulate a biological microenvironment for cells. When creating a bioengineered pancreatic construct, a tissue-specific scaffold obtained from decellularized pancreatic tissue can serve as such matrix....

    Full description

    Get full text
    Article
  13. 13

    Decellularized porcine liver scaffold for maintaining the viability and capacity of pancreatic islets by N. V. Baranova, A. S. Ponomareva, A. D. Belova, L. A. Kirsanova, D. D. Filin, E. A. Nemets, Yu. B. Basok, V. I. Sevastianov

    Published 2025-03-01

    Bioengineered pancreatic constructs based on scaffolds made from decellularized tissues and pancreatic islets (PIs) may be used to extend the functional activity of transplanted PIs in patients with type I diabetes. Objective: to investigate in vitro the effect of decellularized porcine liver scaffo...

    Full description

    Get full text
    Article
  14. 14

    Effect of trypsin on biochemical and functional properties of decellularized porcine articular cartilage by A. D. Kirillova, E. A. Nemets, A. M. Grigoriev, L. A. Kirsanova, V. A. Ryzhikova, E. A. Volkova, Yu. B. Basok, V. I. Sevastianov

    Published 2023-09-01

    Objective: to study the effect of trypsin pretreatment in the porcine articular cartilage decellularization protocol on the ability to restore the biochemical composition and functional properties of the resulting finely dispersed tissue-specific scaffold when co-cultured with human adipose-derived...

    Full description

    Get full text
    Article
  15. 15

    The comparative study of chondrogenic differentiation of mesenchymal stromal cells allocated from different sources by Yu. B. Basok, A. M. Grigoriev, L. A. Kirsanova, I. V. Vakhrushev, A. V. Tsvetkova, A. A. Gryadunova, K. N. Yarygin, V. I. Sevastianov

    Published 2019-05-01

    Introduction. As an alternative to autochondral transplantation, variants of chondrocyte replacement with mesenchymal stromal cells (MSCs) were considered, since these cells are present in all organs and tissues of human body and possess multilinear potential for differentiation. A number of studies...

    Full description

    Get full text
    Article
  16. 16

    Supercritical carbon dioxide as a tool for improving the biocompatible properties of biopolymer and tissue specific scaffolds for tissue engineering by E. A. Nemets, A. E. Lazhko, A. M. Grigoryev, V. Yu. Belov, V. A. Surguchenko, Yu. B. Basok, A. D. Kirillova, V. I. Sevastianov

    Published 2021-07-01

    Objective: to investigate the efficacy of supercritical carbon dioxide (sc-CO2) for enhancштп the biocompatibility of biopolymer scaffolds from biodegradable materials and tissue-specific scaffolds from decellularized porcine liver slices (PLSs) or fine porcine cartilage particles (FPCPs).Materials...

    Full description

    Get full text
    Article
  17. 17

    Biological properties of macroporous cryostructurate based on extracellular matrix components by A. M. Grigoriev, Yu. B. Basok, A. D. Belova, N. P. Shmerko, A. M. Subbot, V. K. Kulakova, V. I. Lozinsky, V. I. Sevastianov

    Published 2024-01-01

    Objective: to study the biological properties of macroporous cryostructurate from multicomponent concentrated collagen-containing solution (MCCS) as a promising matrix for the formation of cell- and tissue-engineered constructs.Materials and methods. A macroporous spongy carrier was obtained by cryo...

    Full description

    Get full text
    Article
  18. 18

    Technique for reducing the surgical porosity of small-diameter vascular grafts by E. A. Nemets, A. I. Khairullina, V. Yu. Belov, V. A. Surguchenko, V. N. Vasilets, V. I. Sevastianov, E. A. Volkova, Yu. B. Basok

    Published 2023-09-01

    High surgical porosity (SP) is one of the causes of significant blood loss, as well as hematoma formation. So, reducing the SP of small-diameter vascular grafts (VGs) is a crucial task.The objective of this work was to develop a technology for the formation of polycaprolactone (PCL)-based small-diam...

    Full description

    Get full text
    Article
  19. 19

    Evaluation of the effect of mesenchymal stromal cells from different sources on human chondrocyte proliferation by A. D. Belova, Yu. B. Basok, A. M. Grigoriev, L. A. Kirsanova, E. G. Kuznetsova, I. V. Vakhrushev, A. V. Kovalev, K. N. Yarygin, V. I. Sevastianov

    Published 2024-01-01

    Objective: to study the effect of a conditioned medium of mesenchymal stromal cells (MSCs) from different sources on human chondrocyte proliferation.Materials and methods. To confirm functional activity, chondrocytes were cultured in a cartilage cell-engineered construct (CEC), including 5 × 105 cel...

    Full description

    Get full text
    Article
  20. 20

    Intraperitoneal injection of cell-engineered pancreas in rats with experimental type i diabetes (preliminary results) by A. S. Ponomareva, N. V. Baranova, A. O. Nikolskaya, L. A. Kirsanova, N. A. Onishchenko, Z. Z. Gonikova, G. N. Bubentsova, Е. A. Volkova, Yu. B. Basok, V. I. Sevastianov

    Published 2023-07-01

    Creation of a bioartificial pancreas, including a cell-engineered construct (CEC) formed from pancreatic islets (islets of Langerhans) and a biocompatible matrix mimicking the native microenvironment of pancreatic tissue, is one of the approaches to the treatment of type 1 diabetes mellitus (T1D).Ob...

    Full description

    Get full text
    Article